Lipid droplets in breast cancer cells
Cell-based study · SUM159 breast cancer cells [1]
For LD area experiments, cells were treated with 10 μM T863 (or equivalent volume of DMSO) 30 min prior to the incubation in 0.5 mM oleic acid containing medium. Each inhibitor reduced lipid droplets (LDs) by ~50% in SUM159 cells incubated in a culture medium containing oleic acid.
| Endpoint | Reported result | Reference |
|---|---|---|
| LD area (% cytoplasm) | LD area (% cytoplasm) ~50% | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 μM
- Exposure duration
- 30 min prior to the incubation; 18 h
- Method
- cells were treated
- Vehicle
- DMSO
- Co-treatment
- Other interventions in this design: oleic acid 0.5 mM. Compound effect isolated by the comparison: equivalent volume of DMSO.
Methods and source locations
Compound reported in the paper: T863
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > The DGAT1 inhibitors T863 and DGAT1N1 inhibit recombinant human DGAT1 (S5); Methods > Fluorescence microscopy (S133, S134, S136); Methods > Quantification of fluorescence images (S145); Fig. 1 legend (S177)
LD area (% cytoplasm): LD area (% cytoplasm); comparator: equivalent volume of DMSO — Results > The DGAT1 inhibitors T863 and DGAT1N1 inhibit recombinant human DGAT1 (S5); Methods > Fluorescence microscopy (S134); Methods > Quantification of fluorescence images (S145)